Artificial Intelligence-Related Voice and Speech Biomarkers of Alzheimer's Disease: A Systematic Review.
BACKGROUND Artificial intelligence (AI)-based voice and speech analysis is emerging as a promising, noninvasive biomarker for Alzheimer's disease (AD) and mild cognitive impairment (MCI). This study aimed to systematically review AI voice and speech models for detecting AD and MCI, and to evaluate their translational p...